Medscape

Imsidolimab is a monoclonal antibody that inhibits interleukin-36 receptor signaling and is administered intravenously. Medscape Medical News

Even the most effective psoriasis therapies can fail if they aren’t taken correctly. Dr Steve Feldman explores adherence breakdowns in

Initiating mepolizumab within 3 months of EGPA diagnosis is associated with a higher remission rate, earlier glucocorticoid withdrawal, and less

Criswell will reportedly stay on as an intramural scientist, continuing to investigate genetic causes of autoimmune diseases. Medscape Medical News

Digital FDG PET/CT can pick up cranial giant cell arteritis that may be missed on ultrasound because of a lack

Experts warn that misinformation about menopausal hormone therapy may be increasing fracture risk in women. Medscape News Europe

Dry eye disease affects many people across different autoimmune diseases, ranging in prevalence from about 23% to 81%, and appears

The use of stable supportive shoes does not reduce 6‑month walking hip pain in adults with chronic hip osteoarthritis more

Dermatologists should anticipate increased utilization management for Part D-covered therapies, including more frequent prior authorization, step therapy requirements, and formulary

More licenses mean more opportunity — and more compliance risk. Ericka Adler discusses what physicians should consider before going multi-state.

European regulators are also conducting a review of avacopan. The issue appears to involve data from the pivotal ADVOCATE trial

In patients with RA, baseline comorbidities measured using a rheumatic disease-specific index, whether or not including lung disease, are linked

A consensus statement with more specific guidance on communication practices may help standardize approaches to vaccine-related communication with families, author

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain

Reducing the dose of biologic drugs may not match standard treatment in preventing disease flares at 1 year in patients

Read clinically focused news coverage of key developments from IVW 2026. Medscape Rheumatology

A national analysis finds pediatric dermatology hospitalizations have fallen sharply since 2012, but disparities by race, income, and insurance persist.

Social media may glamorize athletes’ diets, but restrictive eating combined with intense training can produce low energy availability, menstrual dysfunction,

Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to

Research suggests a bidirectional relationship between posttraumatic stress disorder and fibromyalgia in military service members exposed to combat environments. Medscape

A review of exercise clinical trials in osteoarthritis finds the evidence is inconclusive and shows only negligible or short-lasting benefits.

A 10-year study shows that a multipronged approach using whole exome sequencing can improve diagnostic yield in patients with suspected

Patients with systemic lupus erythematosus who receive belimumab monotherapy show comparable remission rates and disease control to those who receive

Most patients with newly diagnosed rheumatoid arthritis can successfully discontinue glucocorticoids after short-term bridging therapy, a new study shows. Medscape

A recent federal appropriations bill carried with it 2-year extensions of telehealth provisions, along with changes in policy intended to

In the rapidly moving field, questions remain regarding long-term safety, durability of remission, and the FDA’s approach to approvals. Medscape

Belimumab combined with standard induction therapy is effective and safe in patients with proliferative lupus nephritis, according to a real-world